Cystatin C is a suitable marker of glomerular function in children with cancer

Edit Bárdi, Ildikó Bobok, Anna V. Oláh, E. Oláh, J. Kappelmayer, C. Kiss

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Antineoplastic chemotherapy is associated with nephrotoxic side effects. Data on nephrotoxicity in childhood cancer are scanty, in part because of the difficulties in obtaining reliable markers of glomerular function. We used serum cystatin C (cysC) to assess glomerular function. CysC was compared with serum creatinine concentration (SCr), the endogenous creatinine clearence (CCr), and the calculated Counahan formula (CCounahan) in children with leukemia and solid tumors. CysC was measured by particle-enhanced immunoturbidimetric assay. Serum and urinary creatinine concentrations were determined by the Jaffé method. Samples were obtained from 258 children, including 92 receiving anticancer chemotherapy, 108 long-term survivors, 40 children without any renal disease, and 18 patients with chronic renal insufficiency. CysC of patients on current chemotherapy was assessed both before and after treatment. Significant correlations were found between cysC and SCr and between 1/cysC and CCounahan. CysC increased significantly after cisplatin, methotrexate, cyclophosphamide, ifosfamide, and multimodality treatment. Our results suggest that cysC measurement can be used to characterize glomerular function in children with cancer.

Original languageEnglish
Pages (from-to)1145-1147
Number of pages3
JournalPediatric Nephrology
Volume19
Issue number10
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Cystatin C
Creatinine
Serum
Drug Therapy
Neoplasms
Ifosfamide
Chronic Renal Insufficiency
Methotrexate
Antineoplastic Agents
Cyclophosphamide
Cisplatin
Survivors
Leukemia
Kidney
Therapeutics

Keywords

  • Childhood cancer
  • Cystatin C
  • Glomerular function

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Cystatin C is a suitable marker of glomerular function in children with cancer. / Bárdi, Edit; Bobok, Ildikó; Oláh, Anna V.; Oláh, E.; Kappelmayer, J.; Kiss, C.

In: Pediatric Nephrology, Vol. 19, No. 10, 10.2004, p. 1145-1147.

Research output: Contribution to journalArticle

Bárdi, Edit ; Bobok, Ildikó ; Oláh, Anna V. ; Oláh, E. ; Kappelmayer, J. ; Kiss, C. / Cystatin C is a suitable marker of glomerular function in children with cancer. In: Pediatric Nephrology. 2004 ; Vol. 19, No. 10. pp. 1145-1147.
@article{fb6b39eccb93486b88405cb67cf74c36,
title = "Cystatin C is a suitable marker of glomerular function in children with cancer",
abstract = "Antineoplastic chemotherapy is associated with nephrotoxic side effects. Data on nephrotoxicity in childhood cancer are scanty, in part because of the difficulties in obtaining reliable markers of glomerular function. We used serum cystatin C (cysC) to assess glomerular function. CysC was compared with serum creatinine concentration (SCr), the endogenous creatinine clearence (CCr), and the calculated Counahan formula (CCounahan) in children with leukemia and solid tumors. CysC was measured by particle-enhanced immunoturbidimetric assay. Serum and urinary creatinine concentrations were determined by the Jaff{\'e} method. Samples were obtained from 258 children, including 92 receiving anticancer chemotherapy, 108 long-term survivors, 40 children without any renal disease, and 18 patients with chronic renal insufficiency. CysC of patients on current chemotherapy was assessed both before and after treatment. Significant correlations were found between cysC and SCr and between 1/cysC and CCounahan. CysC increased significantly after cisplatin, methotrexate, cyclophosphamide, ifosfamide, and multimodality treatment. Our results suggest that cysC measurement can be used to characterize glomerular function in children with cancer.",
keywords = "Childhood cancer, Cystatin C, Glomerular function",
author = "Edit B{\'a}rdi and Ildik{\'o} Bobok and Ol{\'a}h, {Anna V.} and E. Ol{\'a}h and J. Kappelmayer and C. Kiss",
year = "2004",
month = "10",
doi = "10.1007/s00467-004-1548-3",
language = "English",
volume = "19",
pages = "1145--1147",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Cystatin C is a suitable marker of glomerular function in children with cancer

AU - Bárdi, Edit

AU - Bobok, Ildikó

AU - Oláh, Anna V.

AU - Oláh, E.

AU - Kappelmayer, J.

AU - Kiss, C.

PY - 2004/10

Y1 - 2004/10

N2 - Antineoplastic chemotherapy is associated with nephrotoxic side effects. Data on nephrotoxicity in childhood cancer are scanty, in part because of the difficulties in obtaining reliable markers of glomerular function. We used serum cystatin C (cysC) to assess glomerular function. CysC was compared with serum creatinine concentration (SCr), the endogenous creatinine clearence (CCr), and the calculated Counahan formula (CCounahan) in children with leukemia and solid tumors. CysC was measured by particle-enhanced immunoturbidimetric assay. Serum and urinary creatinine concentrations were determined by the Jaffé method. Samples were obtained from 258 children, including 92 receiving anticancer chemotherapy, 108 long-term survivors, 40 children without any renal disease, and 18 patients with chronic renal insufficiency. CysC of patients on current chemotherapy was assessed both before and after treatment. Significant correlations were found between cysC and SCr and between 1/cysC and CCounahan. CysC increased significantly after cisplatin, methotrexate, cyclophosphamide, ifosfamide, and multimodality treatment. Our results suggest that cysC measurement can be used to characterize glomerular function in children with cancer.

AB - Antineoplastic chemotherapy is associated with nephrotoxic side effects. Data on nephrotoxicity in childhood cancer are scanty, in part because of the difficulties in obtaining reliable markers of glomerular function. We used serum cystatin C (cysC) to assess glomerular function. CysC was compared with serum creatinine concentration (SCr), the endogenous creatinine clearence (CCr), and the calculated Counahan formula (CCounahan) in children with leukemia and solid tumors. CysC was measured by particle-enhanced immunoturbidimetric assay. Serum and urinary creatinine concentrations were determined by the Jaffé method. Samples were obtained from 258 children, including 92 receiving anticancer chemotherapy, 108 long-term survivors, 40 children without any renal disease, and 18 patients with chronic renal insufficiency. CysC of patients on current chemotherapy was assessed both before and after treatment. Significant correlations were found between cysC and SCr and between 1/cysC and CCounahan. CysC increased significantly after cisplatin, methotrexate, cyclophosphamide, ifosfamide, and multimodality treatment. Our results suggest that cysC measurement can be used to characterize glomerular function in children with cancer.

KW - Childhood cancer

KW - Cystatin C

KW - Glomerular function

UR - http://www.scopus.com/inward/record.url?scp=4844224901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4844224901&partnerID=8YFLogxK

U2 - 10.1007/s00467-004-1548-3

DO - 10.1007/s00467-004-1548-3

M3 - Article

VL - 19

SP - 1145

EP - 1147

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 10

ER -